Results 21 to 30 of about 633,065 (305)
Outcome of MS relapses in the era of disease-modifying therapy
BMC Neurology, 2017 Background In multiple sclerosis (MS), neurological disability results from incomplete remission of relapses and from relapse-independent progression.
Muriel Stoppe +3 more
doaj +1 more source
Indian Journal of Dermatology, Venereology and Leprology, 2009 Leprosy is unique in terms of the nature of the causative organism (Mycobacterium leprae), the chronicity of the disease, its prolonged treatment and the definitions of "cure" and "relapse." The principal mode of assessing the efficacy of therapeutic regimens in leprosy is the "relapse rate." There are wide variations in estimates of relapse rates ...
Kaimal, Sowmya, Thappa, Devinder Mohan
openaire +2 more sources
Management of Relapsed and Relapsed Refractory Myeloma
Hematology/Oncology Clinics of North America, 2007 Studies of bortezomib, thalidomide, and lenalidomide have shown promising clinical activity in relapsed/refractory multiple myeloma (MM). Bortezomib alone and in combination with other agents is associated with high response rates, consistently high rates of complete response, and a predictable and manageable profile of adverse events.
Kastritis, E. +3 more
openaire +5 more sources
Brain Sciences, 2022 Patients with severe substance use disorders are often characterized by neurocognitive impairments and elevated mental health symptom load, typically associated with craving intensity and substance use relapse.
Anders Dahlen Forsmo Lauvsnes +2 more
doaj +1 more source
Predicting the On-Study Relapse Rate for Multiple Sclerosis Patients in Clinical Trials [PDF]
, 2005 Background: The annual relapse rate has been commonly used as a primary efficacy endpoint in phase III multiple sclerosis (MS) clinical trials. The aim of this study was to determine the relative contribution of different possible prognostic factors ...
Chang, C. +8 more
core +1 more source
Annals of Medicine, 2023 Objective To explore the novel applications of histological factors by stratifying the prognostic markers of the overall CRC patients in subgroups.Materials and methods A total of 17 histopathological and molecular factors were retrospectively collected ...
Yuan Yuan +4 more
doaj +1 more source
Smoking increases the risk of relapse after successful tuberculosis treatment. [PDF]
, 2008 BACKGROUND: Recent tobacco smoking has been identified as a risk factor for developing tuberculosis, and two studies which have investigated its association with relapse of tuberculosis after completion of treatment had conflicting results (and did not ...
d'Arc Lyra Batista, Joanna +3 more
core +1 more source
, 2021 Relapse-free survival for patients experiencing remission of hypertension at 2 years after metabolic surgery (unadjusted Kaplan–Meier curve).
Erik Näslund (147859) +6 more
core +1 more source
Animals, 2021 A multicentre prospective study was performed to assess whether clinical, hematobiochemical, endoscopic and histopathological parameters were associated with mortality, clinical response and relapse of disease in short- and long-term follow-up of a total
Elena Benvenuti +6 more
doaj +1 more source
Real world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: A retrospective multicentre cohort study [PDF]
, 2023 Background Annualized relapse rate (ARR) is used as an outcome measure in multiple sclerosis (MS) clinical trials. Previous studies demonstrated that ARR has reduced in placebo groups between 1990 and 2012.
Emma Tallantyre +24 more
core +1 more source